11-4999913-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004755.2(OR51L1):āc.931C>Gā(p.Leu311Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000354 in 1,609,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004755.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR51L1 | NM_001004755.2 | c.931C>G | p.Leu311Val | missense_variant | 3/3 | ENST00000641819.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR51L1 | ENST00000641819.1 | c.931C>G | p.Leu311Val | missense_variant | 3/3 | NM_001004755.2 | P1 | ||
OR51L1 | ENST00000641624.1 | n.587+2330C>G | intron_variant, non_coding_transcript_variant | ||||||
OR51L1 | ENST00000642056.1 | n.587+2330C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000445 AC: 11AN: 246926Hom.: 0 AF XY: 0.0000600 AC XY: 8AN XY: 133252
GnomAD4 exome AF: 0.0000336 AC: 49AN: 1457246Hom.: 0 Cov.: 32 AF XY: 0.0000511 AC XY: 37AN XY: 724424
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.931C>G (p.L311V) alteration is located in exon 1 (coding exon 1) of the OR51L1 gene. This alteration results from a C to G substitution at nucleotide position 931, causing the leucine (L) at amino acid position 311 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at